2024-11-07 04:47:37
Lam Research Commits $25 Million to COVID-19 Relief and Recovery Efforts
Corporate/ 2023-07-23
Lam Research Commits $25 Million to COVI...

FREMONT,Calif.,April 9,2020-- Lam Research Corp. (Nasdaq: LRCX) today announced that it is committing $25million for global COVID-19 relief ...

Bridge Biotherapeutics Discloses Interim Results from the First Cohort of Phase 2a Study of BBT-401, an Experimental Drug for Ulcerative Colitis
Corporate/ 2023-07-23
Bridge Biotherapeutics Discloses Interim...

The Interim data showed that 3 out of 9 evaluable patients on BBT-401 responded with more than 30% reduction in Total Mayo Score or 25% redu...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release